Skip to content

Mitochondrial Oxygraphy on Subcutaneous and Peri-visceral Adipose Tissue: Influence of Body Composition

Mitochondrial Oxygraphy on Subcutaneous and Peri-visceral Adipose Tissue: Influence of Body Composition

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05417581
Acronym
OxMiTiAd
Enrollment
67
Registered
2022-06-14
Start date
2021-04-14
Completion date
2023-04-12
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Digestive Organs--Cancer, Parietal Region Trauma

Keywords

Mitochondria, Oxygraphy, Adipose Tissue, Body Mass Index, Digestive surgery

Brief summary

The objective of this study is to adapt the oxygraphy technique on human adipocytes and to characterize respiration measurements according to patients' body mass index and white adipose tissue localization (subcutaneous vs visceral).

Detailed description

During digestive surgery: oncological and bariatric surgery, it is possible to collect a small volume of subcutaneous and epiplonic adipose tissue (10-20 cc). We wish to collect these samples in order to develop the technique of oxygenography on permeabilized adipocytes. In order to characterize these measurements, they will be related to the clinical data of the patients usually collected in the framework of the preoperative assessment including the body mass index (BMI). The measured adipocyte data will thus be normalized to three BMI classes: ≤ 20, \> to 20 \< 30, and ≥ to 30 kg∙m-2. Primary end point is to validate the measurement of mitochondrial respiration under oxidophosphorylating conditions by determining indicators of the distribution of mitochondrial respiration values (mean, standard deviation, skewness, kurtosis, coefficient of variation) as a function of patients' body mass index.

Interventions

PROCEDUREadipose surgery

A quantity of adipose tissue equivalent to 10-20 cubic centimeter will be removed subcutaneously and from the omentum during surgical procedures (oncological, bariatric)

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

all participants receive the same intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing oncological, bariatric, parietal surgery * Patients able to give an informed consent * Patients affiliated to an Health Care insurance * Patients aged over 18

Exclusion criteria

* Patients under guardianship, curatorship or deprived of freedom * Pregnant or breastfeeding women * Participation refusal * Patients under chemotherapy * Patients with peritonitis and infectious parietal processes

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of mitochondrial respiration on adipose tissue by oxygraphyday 1Mitochondrial respiration measurements in oxydophosphorylated conditions. For each patient measurements using ADP and carbohydrate or lipid substrates of the respiratory chain complexes for both the subcutaneous and the visceral tissue.

Secondary

MeasureTime frameDescription
mitochondrial respiration values depending on patients BMI by oxygraphyday 1Identification of mitochondrial respiration discrimination factors
comparing mitochondrial respiration values depending on tissue location by oxygraphyday 1Identification of mitochondrial respiration discrimination factors
comparing mitochondrial respiration values depending on anthropometric data by oxygraphyday 1Identification of mitochondrial respiration discrimination factors

Countries

France

Contacts

PRINCIPAL_INVESTIGATORRuddy RICHARD

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026